|
⚲
|
| Keyboard |
| Naesens Janwillem
✚
|
|
|---|---|
| CIK # | 0001864377 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001864377] | |
| 4 | [0001864377] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cyteir Therapeutics Inc | |
| Naesens Janwillem | |
| Verelst Luc | |
| Wepaven BV | |
| IHL Sa | |
| Droia Invest II SCSp | |
| DF II GP Sarl |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cyteir Therapeutics Inc CYT
Stock Option (Right to Buy) · derivative
|
2022-02-22 | Grant | 14,150 | $0.00 | |
|
Cyteir Therapeutics Inc CYT
Common Stock
|
2021-06-22 | Buy | 277,777 | $18.00 | 4,999,986 |
|
Cyteir Therapeutics Inc CYT
Series C Convertible Preferred Stock · derivative
|
2021-06-22 | Conversion | 1,109,368 | ||
|
Cyteir Therapeutics Inc CYT
Series B Convertible Preferred Stock · derivative
|
2021-06-22 | Conversion | 10,000,000 | ||
|
Cyteir Therapeutics Inc CYT
Common Stock
|
2021-06-22 | Conversion | 3,259,026 | ||
|
Cyteir Therapeutics Inc CYT
Common Stock
|
2021-06-22 | Conversion | 3,259,026 | ||
|
Cyteir Therapeutics Inc CYT
Series B Convertible Preferred Stock · derivative
|
2021-06-22 | Conversion | 10,000,000 | ||
|
Cyteir Therapeutics Inc CYT
Series C Convertible Preferred Stock · derivative
|
2021-06-22 | Conversion | 1,109,368 | ||
|
Cyteir Therapeutics Inc CYT
Common Stock
|
2021-06-22 | Buy | 277,777 | $18.00 | 4,999,986 |